Ensign Peak Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,959
Closed -$83.6K 1742
2026
Q1
$83.6K Hold
13,959
﹤0.01% 1608
2025
Q4
$100K Sell
13,959
-30,850
-69% -$244K ﹤0.01% 1570
2025
Q3
$479K Sell
44,809
-8,950
-17% -$87.8K ﹤0.01% 1403
2025
Q2
$520K Sell
53,759
-15,250
-22% -$157K ﹤0.01% 1543
2025
Q1
$1.03M Hold
69,009
﹤0.01% 1229
2024
Q4
$1.03M Hold
69,009
﹤0.01% 1302
2024
Q3
$1.32M Hold
69,009
﹤0.01% 1160
2024
Q2
$1.43M Hold
69,009
﹤0.01% 1059
2024
Q1
$1.3M Sell
69,009
-3,481
-5% -$59.7K ﹤0.01% 1154
2023
Q4
$1.05M Hold
72,490
﹤0.01% 1344
2023
Q3
$1.26M Hold
72,490
﹤0.01% 1027
2023
Q2
$1.51M Sell
72,490
-9,020
-11% -$196K ﹤0.01% 982
2023
Q1
$1.92M Buy
81,510
+3,592
+5% +$96.4K ﹤0.01% 870
2022
Q4
$2.18M Sell
77,918
-2,777
-3% -$71K ﹤0.01% 782
2022
Q3
$1.89M Buy
80,695
+2,840
+4% +$85.7K ﹤0.01% 800
2022
Q2
$2.63M Sell
77,855
-8,385
-10% -$294K 0.01% 707
2022
Q1
$3.01M Buy
86,240
+20,515
+31% +$702K 0.01% 729
2021
Q4
$2M Sell
65,725
-48,337
-42% -$1.57M ﹤0.01% 956
2021
Q3
$3.74M Sell
114,062
-156,611
-58% -$5.01M 0.01% 775
2021
Q2
$8.19M Buy
+270,673
New +$8.91M 0.02% 483

Other funds holding OGN

Ensign Peak Advisors's OGN Position: Q2 2026 in Review

Ensign Peak Advisors sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 13,959 shares — an estimated $83.6K sold.

Ensign Peak Advisors first reported a position in OGN in Q2 2021 and held it in 20 quarters. The position peaked at $8.19M in Q2 2021. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Ensign Peak Advisors reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Ensign Peak Advisors sold 13,959 Organon & Co shares in Q2 2026, an estimated $83.6K.
  • Ensign Peak Advisors first reported a position in Organon & Co in Q2 2021 and held it in 20 quarters.
  • Ensign Peak Advisors's Organon & Co position peaked at $8.19M in Q2 2021.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.